Vaccine to protect seniors from RSV ready for FDA review, drugmaker says
Alicia Lasek (f3)
Jun 13, 2022
A vaccine to help prevent a leading cause of pneumonia in the elderly has been found effective in late-stage clinical trials.
GlaxoSmithKline plans Shingrix push; new RSV shot for elders in works
Jun 28, 2021
GSK’s shingles vaccine will get a renewed marketing push following a large drop in sales during the pandemic, and the company is aiming to launch a fast-tracked shot for a common respiratory virus...
Adult immunizations fell dramatically during pandemic, vaccine maker says
Jun 14, 2021
In total, 17.2 million adult vaccine doses were missed in 2020. And immunizations continue to lag well behind 2019 levels, reports GlaxoSmithKline.
FDA OKs third antibody COVID therapy; variants spur new pause on another
Jun 01, 2021
A new COVID-19 treatment made by GlaxoSmithKline now is the third monoclonal antibody therapy federally authorized to help prevent severe disease outcomes in high-risk patients. But gene variants are interfering...
Pharma companies embrace branding
Mar 01, 2014
Big pharmaceutical companies are exploring “brand personality” in their marketing strategies, according to new research.
FDA approves Anoro Ellipta
Dec 20, 2013
The U.S. Food and Drug Administration have approved GlaxoSmithKline’s Anoro™ Ellipta™, the company announced. The product is used to treat chronic obstructive pulmonary disease.
Glaxo will stop paying doctors for speaking gigs in industry-leading change
Dec 18, 2013
Pharmaceutical giant GlaxoSmithKline will stop paying healthcare professionals to speak about its products, and will alter other marketing and compensation practices that are common in the industry but...
‘Landmark’ discovery brings a pill for Alzheimer’s closer to reality, researchers say
Oct 15, 2013
The discovery of a compound that stops diseases like Alzheimer’s and Parkinson’s in their tracks is a “landmark” step toward a pill to treat these conditions, according to researchers...
Flu vaccines approved to ship
Aug 07, 2013
GlaxoSmithKline said it has received Food and Drug Administration approval to start shipping the 2013-2014 influenza virus vaccine to Centers for Disease Control and Prevention distribution centers and...
Avandia gets FDA win, but is unlikely to dominate market again
Jun 10, 2013
A Food and Drug Administration advisory panel has voted to ease measures that limit patient access to the diabetes pill Avandia. Many panelists, however, said precautions are still needed.